Combining xenon and mild therapeutic hypothermia preserves neurological function after prolonged cardiac arrest in pigs

Critical Care Medicine

Volumn 40, Issue 4, 2012, Pages 1297-1303

  Fries, Michael ^a   Brücken, Anne ^a   Çizen, Ayşegül ^a   Westerkamp, Maren ^a   Löwer, Céline ^a   Deike Glindemann, Jan ^a   Schnorrenberger, Nora K ^a   Rex, Steffen ^a   Coburn, Mark ^a   Nolte, Kay W ^a   Weis, Joachim ^a   Rossaint, Rolf ^a   Derwall, Matthias ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

cardiac arrest; cardiopulmonary resuscitation; cerebral ischemia; induced hypothermia; swine; xenon

Indexed keywords

GLUCOSE; LACTIC ACID; XENON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASTROCYTOSIS; BRAIN CORTEX; BRAIN NECROSIS; CAUDATE NUCLEUS; CONTROLLED STUDY; HEART ARREST; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART OUTPUT; HEART RATE; HIPPOCAMPUS; HISTOPATHOLOGY; INDUCED HYPOTHERMIA; LUNG ARTERY PRESSURE; MALE; MEAN ARTERIAL PRESSURE; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RESUSCITATION; REVIEW; SURVIVAL; SWINE;

ADMINISTRATION, INHALATION; ANIMALS; BRAIN; CARDIOPULMONARY RESUSCITATION; DISEASE MODELS, ANIMAL; HEART ARREST; HYPOTHERMIA, INDUCED; HYPOXIA, BRAIN; MALE; NEUROPROTECTIVE AGENTS; SWINE; XENON;

EID: 84858788422     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31823c8ce7     Document Type: Review

References (48)

1. Nolan J, Laver S: Outcome of out-of-hospital cardiac arrest. Anaesthesia 2007; 62:1082-1083; author reply 1083
2. Olasveengen TM, Sunde K, Brunborg C, et al: Intravenous drug administration during out-of-hospital cardiac arrest: A randomized trial. JAMA 2009; 302:2222-2229
3. Neumar RW, Nolan JP, Adrie C, et al: Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation 2008; 118:2452-2483
4. Laver S, Farrow C, Turner D, et al: Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med 2004; 30:2126-2128
5. Derwall M, Coburn M, Rex S, et al: Xenon: Recent developments and future perspectives. Minerva Anestesiol 2009; 75:37-45
6. Franks NP, Dickinson R, de Sousa SL, et al: How does xenon produce anaesthesia? Nature 1998; 396:324
7. Rossaint R, Reyle-Hahn M, Schulte Am Esch J, et al: Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 2003; 98:6-13
8. Wappler F, Rossaint R, Baumert J, et al: Multicenter randomized comparison of xenon and isoflurane on left ventricular function in patients undergoing elective surgery. Anesthesiology 2007; 106:463-471
9. Coburn M, Maze M, Franks NP: The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit Care Med 2008; 36:588-595
10. David HN, Leveille F, Chazalviel L, et al: Reduction of ischemic brain damage by nitrous oxide and xenon. J Cereb Blood Flow Metab 2003; 23:1168-1173
11. Dingley J, Tooley J, Porter H, et al: Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke 2006; 37:501-506
12. Luo Y, Ma D, Ieong E, et al: Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology 2008; 109:782-789
13. Ma D, Wilhelm S, Maze M, et al: Neuroprotective and neurotoxic properties of the 'inert' gas, xenon. Br J Anaesth 2002; 89:739-746
14. Schmidt M, Marx T, Glöggl E, et al: Xenon attenuates cerebral damage after ischemia in pigs. Anesthesiology 2005; 102:929-936
15. Weber NC, Toma O, Wolter JI, et al: Mechanisms of xenon-and isoflurane-induced preconditioning-a potential link to the cytoskeleton via the MAPKAPK-2/HSP27 pathway. Br J Pharmacol 2005; 146:445-455
16. Tu W, Xu X, Peng L, et al: DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 2010; 140:222-234
17. Taghibiglou C, Martin HG, Lai TW, et al: Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries. Nat Med 2009; 15:1399-1406
18. Fries M, Nolte KW, Coburn M, et al: Xenon reduces neurohistopathological damage and improves the early neurological deficit after cardiac arrest in pigs. Crit Care Med 2008; 36:2420-2426
19. Fries M, Coburn M, Nolte KW, et al: Early administration of xenon or isoflurane may not improve functional outcome and cerebral alterations in a porcine model of cardiac arrest. Resuscitation 2009; 80:584-590
20. Hobbs C, Thoresen M, Tucker A, et al: Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke 2008; 39:1307-1313
21. Ma D, Hossain M, Chow A, et al: Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005; 58:182-193
22. Martin JL, Ma D, Hossain M, et al: Asynchronous administration of xenon and hypothermia significantly reduces brain infarction in the neonatal rat. Br J Anaesth 2007; 98:236-240
23. Thoresen M, Hobbs CE, Wood T, et al: Cooling combined with immediate or delayed xenon inhalation provides equivalent long-term neuroprotection after neonatal hypoxia-ischemia. J Cereb Blood Flow Metab 2009; 29:707-714
24. Derwall M, Timper A, Kottmann K, et al: Neuroprotective effects of the inhalational anesthetics isoflurane and xenon after cardiac arrest in pigs. Crit Care Med 2008; 36:S492-S495
25. Derwall M, Westerkamp M, Löwer C, et al: Hydrogen sulfide does not increase resuscitability in a porcine model of prolonged cardiac arrest. Shock 2010; 34:190-195
26. Fries M, Nolte K, Demir F, et al: Neurocognitive performance after cardiopulmonary resuscitation in pigs. Crit Care Med 2008; 36:842-847
27. Fries M, Bickenbach J, Henzler D, et al: S-100 protein and neurohistopathologic changes in a porcine model of acute lung injury. Anesthesiology 2005; 102:761-767
28. Behringer W, Prueckner S, Kentner R, et al: Rapid hypothermic aortic flush can achieve survival without brain damage after 30 minutes cardiac arrest in dogs. Anesthesiology 2000; 93:1491-1499
29. Janata A, Weihs W, Schratter A, et al: Cold aortic flush and chest compressions enable good neurologic outcome after 15 mins of ventricular fibrillation in cardiac arrest in pigs. Crit Care Med 2010; 38:1637-1643
30. Hypothermia after Cardiac Arrest Study Group: Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346:549-556
31. Bernard SA, Gray TW, Buist MD, et al: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346:557-563
32. Holzer M, Bernard SA, Hachimi-Idrissi S, et al: Hypothermia for neuroprotection after cardiac arrest: Systematic review and individual patient data meta-analysis. Crit Care Med 2005; 33:414-418
33. Peberdy MA, Callaway CW, Neumar RW, et al: Part 9: Post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S768-S786
34. Chakkarapani E, Dingley J, Liu X, et al: Xenon enhances hypothermic neuroprotection in asphyxiated newborn pigs. Ann Neurol 2010; 68:330-341
35. Ji X, Luo Y, Ling F, et al: Mild hypothermia diminishes oxidative DNA damage and pro-death signaling events after cerebral ischemia: A mechanism for neuroprotection. Front Biosci 2007; 12:1737-1747
36. Ooboshi H, Ibayashi S, Takano K, et al: Hypothermia inhibits ischemia-induced efflux of amino acids and neuronal damage in the hippocampus of aged rats. Brain Res 2000; 884:23-30
37. Schmitt KR, Diestel A, Lehnardt S, et al: Hypothermia suppresses inflammation via ERK signaling pathway in stimulated microglial cells. J Neuroimmunol 2007; 189:7-16
38. Zhao H, Yenari MA, Sapolsky RM, et al: Mild postischemic hypothermia prolongs the time window for gene therapy by inhibiting cytochrome C release. Stroke 2004; 35:572-577
39. Bantel C, Maze M, Trapp S: Noble gas xenon is a novel adenosine triphosphate-sensitive potassium channel opener. Anesthesiology 2010; 112:623-630
40. Gruss M, Bushell TJ, Bright DP, et al: Two-pore-domain K1 channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 2004; 65:443-452
41. Baumert JH, Hein M, Hecker KE, et al: Autonomic cardiac control with xenon anaesthesia in patients at cardiovascular risk. Br J Anaesth 2007; 98:722-727
42. Hartlage MA, Berendes E, Van Aken H, et al: Xenon improves recovery from myocardial stunning in chronically instrumented dogs. Anesth Analg 2004; 99:655-664, table of contents
43. Preckel B, Müllenheim J, Moloschavij A, et al: Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth Analg 2000; 91:1327-1332
44. Baumert JH, Hecker KE, Hein M, et al: Haemodynamic effects of haemorrhage during xenon anaesthesia in pigs. Br J Anaesth 2005; 94:727-732
45. Francis RC, Philippi-Höhne C, Klein A, et al: Xenon/remifentanil anesthesia protects against adverse effects of losartan on hemodynamic challenges induced by anesthesia and acute blood loss. Shock 2010; 34:628-635
46. Laurent I, Monchi M, Chiche JD, et al: Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 2002; 40:2110-2116
47. Tang W, Weil MH, Sun S, et al: Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 1995; 92:3089-3093
48. Dumas F, Grimaldi D, Zuber B, et al: Is hypothermia after cardiac arrest effective in both shockable and nonshockable patients?: Insights from a large registry. Circulation 2011; 123:877-886